ESC 365 - Cost-effectiveness of telerehabilitation

EAPC Premium Access

Cost-effectiveness of telerehabilitation

Session: Cardiovascular prevention: is it worth the money?

Topic: Public Health and Health Economics

Speaker: Doctor I. Frederix (Edegem, BE)

Event: EuroPrevent 2019

Congress Presentation

About the speaker

Doctor Ines Frederix

University of Antwerp, Edegem (Belgium)

4 presentations

0 follower

3 more presentations in this session

The economic burden of cardiovascular disease.

Speaker: Professor F. Pinto (Lisbon, PT)

Cost-effectiveness of primary prevention.

Speaker: Professor O. Franco Duran (Bern, CH)

Cost-effectiveness of secondary prevention

Speaker: Ms G. Shields (Manchester, GB)

Access the full session

Cardiovascular prevention: is it worth the money?

Speakers: Doctor I. Frederix, Professor F. Pinto, Professor O. Franco Duran, Ms G. Shields

About the event

EuroPrevent 2019

11 April - 13 April 2019

Sessions Presentations

Congress

Related content

Open Access

Transforming Outcomes for Patients with hATTR Amyloidosis.

27 August 2021

Open Access

Time for change: Why early intervention matters.

29 June 2021

Open Access

Tracing the origins and treating progression in hereditary ATTR amyloidosis with polyneuropathy.

29 June 2021

ESC 365 is supported by